Education
About Us
Working with TipRanks
Follow Us
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
Total Valuation
Fulgent Genetics has a market cap or net worth of $598.52M. The enterprise value is $540.11M.
Market Cap$598.52M
Enterprise Value$540.11M
Share Statistics
Fulgent Genetics has 30,443,596 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,443,596
Owned by Insiders35.28%
Owned by Institutions<0.01%
Financial Efficiency
Fulgent Genetics’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.43%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-5.43%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee215.89K
Profits Per Employee-33.37K
Employee Count1,313
Asset Turnover0.23
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Fulgent Genetics is -13.08. Fulgent Genetics’s PEG ratio is -2.63.
PE Ratio-13.08
PS Ratio0.00
PB Ratio0.54
Price to Fair Value0.49
Price to FCF-18.97
Price to Operating Cash Flow64.87
PEG Ratio-2.63
Income Statement
In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.
Revenue283.47M
Gross Profit107.22M
Operating Income-73.92M
Pretax Income-51.96M
Net Income-42.71M
EBITDA-48.99M
Earnings Per Share (EPS)-1.41
Cash Flow
In the last 12 months, operating cash flow was 9.36M and capital expenditures -40.98M, giving a free cash flow of -31.61M billion.
Operating Cash Flow9.36M
Free Cash Flow-31.61M
Free Cash Flow per Share-1.04
Dividends & Yields
Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-9.36%
50-Day Moving Average18.02
200-Day Moving Average19.33
Relative Strength Index (RSI)58.84
Average Volume (3m)401.78K
Important Dates
Fulgent Genetics upcoming earnings date is Aug 1, 2025, TBA Not Confirmed.
Last Earnings DateMay 2, 2025
Next Earnings DateAug 1, 2025
Ex-Dividend Date―
Financial Position
Fulgent Genetics as a current ratio of 4.85, with Debt / Equity ratio of 0.68%
Current Ratio4.85
Quick Ratio4.85
Debt to Market Cap<0.01
Net Debt to EBITDA0.95
Interest Coverage Ratio-434.81
Taxes
In the past 12 months, Fulgent Genetics has paid -8.14M in taxes.
Income Tax-8.14M
Effective Tax Rate0.16
Enterprise Valuation
Fulgent Genetics EV to EBITDA ratio is -10.45, with an EV/FCF ratio of -26.58.
EV to Sales1.81
EV to EBITDA-10.45
EV to Free Cash Flow-26.58
EV to Operating Cash Flow24.30
Balance Sheet
Fulgent Genetics has $320.32M in cash and marketable securities with $7.66M in debt, giving a net cash position of -$312.66M billion.
Cash & Marketable Securities$320.32M
Total Debt$7.66M
Net Cash-$312.66M
Net Cash Per Share-$10.27
Tangible Book Value Per Share$32.15
Margins
Gross margin is 38.12%, with operating margin of -26.08%, and net profit margin of -15.07%.
Gross Margin38.12%
Operating Margin-26.08%
Pretax Margin-18.33%
Net Profit Margin-15.07%
EBITDA Margin-17.28%
EBIT Margin-26.08%
Analyst Forecast
The average price target for Fulgent Genetics is $22.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$22.67
Price Target Upside13.12% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast1.71%
EPS Growth Forecast76.00%